First presentation of detailed Phase 2 results following previous positive topline announcement that study of NTLA-2002 met primary and all…
CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug…
National leader in home health and hospice care to extend AI-enabled speech, language, and cognitive therapy initiative across its network…
MENLO PARK, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka” or the “Company”) (Nasdaq: ORKA), a biotechnology…
Centers for Disease Control and Prevention (CDC) reports death rate due to COVID-19 has continued to increase throughout 2024 Immunocompromised…
SER-155 administration was associated with a significant reduction in both bacterial bloodstream infections (BSIs) and systemic antibiotic exposure, as well…
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and…
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard…
Former Chief Business Leader of Philips’ multi-billion-dollar Precision Diagnosis division and member of Philips’ Executive CommitteeEnd-to-end responsibility for Philip’s CT,…
New Advisory Board Member will focus on Venowave sales and business development effortsToronto, Ontario--(Newsfile Corp. - September 12, 2024) -…